Unknown

Dataset Information

0

MiR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.


ABSTRACT: MicroRNAs (miRNAs) family, which is involved in cancer development, proliferation, apoptosis, and drug resistance, is a group of noncoding RNAs that modulate the expression of oncogenes and antioncogenes. Doxorubicin is an active cytotoxic agent for breast cancer treatment, but the acquisition of doxorubicin resistance is a common and critical limitation to cancer therapy. The aim of this study was to investigate whether miR-193b mediated the resistance of breast cancer cells to doxorubicin by targeting myeloid cell leukemia-1 (MCL-1). In this study, we found that miR-193b levels were significantly lower in doxorubicin-resistant MCF-7 (MCF-7/DOXR) cells than in the parental MCF-7 cells. We observed that exogenous miR-193b significantly suppressed the ability of MCF-7/DOXR cells to resist doxorubicin. It demonstrated that miR-193b directly targeted MCL-1 3'-UTR (3'-Untranslated Regions). Further studies indicated that miR-193b sensitized MCF-7/DOXR cells to doxorubicin through a mechanism involving the downregulation of MCL-1. Together, our findings provide evidence that the modulation of miR-193b may represent a novel therapeutic target for the treatment of breast cancer.

SUBMITTER: Long J 

PROVIDER: S-EPMC4615858 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.

Long Jingpei J   Ji Zhiwei Z   Jiang Kai K   Wang Zhaoyang Z   Meng Guanmin G  

BioMed research international 20151007


MicroRNAs (miRNAs) family, which is involved in cancer development, proliferation, apoptosis, and drug resistance, is a group of noncoding RNAs that modulate the expression of oncogenes and antioncogenes. Doxorubicin is an active cytotoxic agent for breast cancer treatment, but the acquisition of doxorubicin resistance is a common and critical limitation to cancer therapy. The aim of this study was to investigate whether miR-193b mediated the resistance of breast cancer cells to doxorubicin by t  ...[more]

Similar Datasets

| S-EPMC3204027 | biostudies-literature
| S-ECPF-GEOD-24996 | biostudies-other
| S-EPMC6909793 | biostudies-literature
2010-10-30 | GSE24996 | GEO
2010-10-30 | E-GEOD-24996 | biostudies-arrayexpress
| S-EPMC6930394 | biostudies-literature
| S-EPMC10046630 | biostudies-literature
| S-EPMC10576278 | biostudies-literature
| S-EPMC4697837 | biostudies-literature
| S-EPMC5224842 | biostudies-literature